SNPS.BK Specialty Natural Products PCL
- Market cap
- THB 1.77B
- P/E
- 16.2x
- P/B
- 2.05x
- ROE
- 10.6%
- Dividend yield
- 4.57%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SNPS.BK undervalued?
Graham numberSNPS.BK trades 21.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Specialty Natural Products PCL fundamental analysis
No fundamental analysis for Specialty Natural Products PCL yet.
Specialty Natural Products PCL stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Specialty Natural Products PCL
Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antiox…
Full company profileSpecialty Natural Products PCL financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Specialty Natural Products PCL annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 708M | 493M | 357M | 457M | 554M | 500M |
| Gross Profit | 291M | 162M | 131M | 186M | 226M | 200M |
| Operating Income | 201M | 92.6M | 43.6M | 94.7M | 121M | 95.2M |
| EBITDA | 233M | 119M | 70.5M | 122M | 147M | 121M |
| Net Income | 170M | 77.9M | 36.8M | 81.1M | 112M | 91.9M |
| EPS | 0.42 | 0.19 | 0.09 | 0.20 | 0.28 | 0.23 |
| Balance Sheet | ||||||
| Total Assets | 750M | 712M | 672M | 988M | 1.02B | 1.00B |
| Total Liabilities | 171M | 291M | 191M | 91.0M | 99.5M | 113M |
| Shareholders' Equity | 557M | 405M | 446M | 866M | 897M | 865M |
| Cash & Short-term Investments | 165M | 235M | 210M | 505M | 494M | 411M |
| Total Debt | 79.8M | 231M | 138M | 4.73M | 2.74M | 31.7M |
| Cash Flow | ||||||
| Operating Cash Flow | 55.6M | 169M | 57.8M | 103M | 86.1M | 480K |
| Capital Expenditure | 27.0M | 18.2M | 11.4M | 11.6M | 13.8M | 12.5M |
| Free Cash Flow | 28.6M | 151M | 46.4M | 91.0M | 72.3M | -12.0M |
| Ratios | ||||||
| ROE | 30.5% | 19.2% | 8.2% | 9.4% | 12.5% | 10.6% |
| ROA | 22.6% | 10.9% | 5.5% | 8.2% | 10.9% | 9.1% |
| Net Profit Margin | 23.9% | 15.8% | 10.3% | 17.7% | 20.2% | 18.4% |
| Debt to Equity | 0.14x | 0.57x | 0.31x | 0.01x | 0.00x | 0.04x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Specialty Natural Products PCL dividends
- Dividend yield
- 4.57%
- Forward dividend
- 0.19 THB
- Payout ratio
- 72.4%
- Ex-dividend date
- May 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 81.0M | 0.20 | 72.4% |
| 2024 | THB 90.0M | 0.22 | 111.0% |
| 2023 | - | - | - |
| 2022 | THB 328M | 0.81 | 420.6% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Specialty Natural Products PCL
- Insiders 93.83%
- Institutions 0.00%
- Public & others 6.17%
- Shares outstanding 405M
- Free float 90.0M
Specialty Natural Products PCL company profile
- Company name
- Specialty Natural Products PCL
- Ticker
- SNPS.BK
- Exchange
- Thailand Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Fiscal year end
- December
- Address
- 700/364 Moo 6, Chonburi, Thailand, 20000
- Phone
- 66 3 845 8698
- Website
- snpthai.com
About Specialty Natural Products PCL
Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active pharmaceuticals ingredients comprising senna extract liquid and andrographis extract powder; packing services for cosmetics, beverages, and dietary supplements; production and distribution of electricity; and product research and development services. The company was incorporated in 1999 and is headquartered in Chonburi, Thailand.
Specialty Natural Products PCL management
6- Dr. Theeraya KrisdaphongCEO & Executive Director · born 1990
- Dr. Panvipa KrisdaphongExecutive Vice Chairman of the Board of Directors · born 1961
- Mr. Suttisak JedsadapaisidCOO & Executive Director · born 1984
- Dr. Krisada KittigowittanaChief Research and Development Officer & Executive Director · born 1980
- Mr. Thanuwatt JaimsuwanChief Financial Officer
- Ms. Wanwisa ThongartCompany Secretary